Last reviewed · How we verify

NCT05979870: AI-CMR

Artificial Intelligence in New Cardiac MR Markers for Congenital Heart Disease

ENROLLING BY INVITATION Last updated 15 May 2025
What this trial tests

trial testing Valvuloplasty, in Aortic Valve Disease in 45 participants. Enrolling by invitation.

Timeline
1 October 2022
Primary endpoint
31 December 2028
31 December 2028

Quick facts

Lead sponsorSahlgrenska University Hospital
StatusENROLLING BY INVITATION
Study typeOBSERVATIONAL
Enrollment45
Start date1 October 2022
Primary completion31 December 2028
Estimated completion31 December 2028
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Sahlgrenska University Hospital

Who can join

Adults 1 Week to 18, any sex, with Aortic Valve Disease or Pulmonary Valve Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to investigate children with aortic and pulmonary valve disease treated or untreated longitudinally. Established CMR measures with additional newly developped, promising, highly refined and clinically applicable quantitative imaging biomarkers, will be utilized as compared to the conventional CMR estimates. The main question\[s\] it aims to answer are: * \[question 1\]To evaluate risk stratification for surgery and intervention of the aortic- and pulmonary valve * \[question 2\]Investigate the cardiac and vascular hemodynamic and morphological changes before and after interventional or surgical treatment of the aortic- and pulmonary valve at short and long term. Participants will undergo cardiac MRI before and after interventional or surgical treatment of the aortic or pulmonary valve Researchers will compare MRI data to an age matched control group established at the department in another study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Aortic Valve Disease

Currently open trials in the same condition.

Other Sahlgrenska University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05979870.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing